Strong M&A momentum in 2026, fueled by record private-equity dry powder near $1.1 trillion, abundant strategic capital, and AI-driven repositioning, supports elevated acquisition activity through year-end. Global deal value is tracking toward $4 trillion, with megadeals accounting for nearly half and recent examples including SpaceX’s $250 billion xAI purchase alongside large cross-border and carve-out transactions. Lower borrowing costs relative to prior years, resilient equity markets, and a more navigable U.S. regulatory backdrop have narrowed valuation gaps and accelerated timelines. Key swing factors include any further Fed policy shifts, antitrust outcomes on large tech or pharma deals, and seasonal deal closings before December 31. Traders weigh these macro and sector-specific catalysts when assessing probabilities for specific targets resolving before 2027.